Single-cell transcriptome analysis reveals atypical monocytes circulating ahead of acute graft-versus-host disease clinical onset
Journal of Leukocyte Biology · 2025
DOI: 10.1093/jleuko/qiae229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2025. Verfasst von Filipe Martins und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Virology and Genetics (LVG), Swiss Federal Institute of Technology Lausanne (Ecole Polytechnique Fédérale de Lausanne, EPFL), School of…. Hauptthemen laut MEDLINE: Graft vs Host Disease, Monocytes, Single-Cell Analysis, Gene Expression Profiling. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CANSEARCH foundation, European Research Council, KRABnKAP.
Abstract (Originalsprache)
Acute graft-versus-host disease (aGVHD) represents the rejection of the recipient's skin, gut, and liver tissues of an allogeneic hematopoietic stem cell transplantation (HSCT) by the donor T cells. The onset of aGVHD is often rapid and its evolution is unpredictable. We undertook the single-cell RNA sequencing of peripheral blood mononuclear cells collected before aGVHD clinical onset in 3 patients and from 1 patient afterward. We used 4 HSCT recipients who remained free of aGVHD as controls. This analysis unveiled the presence of particular subpopulations of circulating monocytes and cytotoxic T cells (CTLs) in pre-aGVHD samples up to 18 d before clinical disease. These pre-aGVHD monocytes were characterized by an upregulation of the M2 polarity marker CD163 and the transmembrane protein SIGLEC1/CD169. At the same time, their CTL counterparts stood out for the upregulation of the CXCL10 receptor CXCR3 and the antigenic stimulation marker CD70. The occurrence of CD163/SIGLEC1 co-expressing monocytes upstream of aGVHD onset was validated using transcriptomic data from an independent cohort and by flow cytometry in additional blood samples. These findings point to potential early diagnostic tools and preventive therapeutic strategies for aGVHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Virology and Genetics (LVG), Swiss Federal Institute of Technology Lausanne (Ecole Polytechnique Fédérale de Lausanne, EPFL), School of Life Sciences, EPFL-SV-GHI-LVG, Station 11, CH-1015 Lausanne, Switzer…
- Clinics of Medical Oncology, HFR Fribourg-Hôpital Cantonal, Ch. des Pensionnats 2/6, CH-1752 Villars-sur-Glâne, Switzerland.
- Cansearch Research Platform for Pediatric Oncology and Hematology, Faculty of Medicine, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Rue de la Corraterie 12, CH-1204 Geneva, Switzerland.
- Division of Pediatric Oncology and Hematology, Department of Women, Child and Adolescent, University Geneva Hospitals, Rue Willy-Donzé 6, CH-1211 Geneva, Switzerland.
ORCID-Profile: Filipe Martins
Förderung
- CANSEARCH foundation
- European Research Council
- KRABnKAP
- Transpos-X
- Personalized Health and Related Technologies
- Swiss Federal Institutes of Technology
- Swiss Personalized Health Network
- Swiss Academy of Medical Sciences
Zitieren
APA
Martins, F., Planet, E., Marino, D., Ansari, M., & Trono, D. (2025). Single-cell transcriptome analysis reveals atypical monocytes circulating ahead of acute graft-versus-host disease clinical onset. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae229
Vancouver
Martins F, Planet E, Marino D, Ansari M, Trono D. Single-cell transcriptome analysis reveals atypical monocytes circulating ahead of acute graft-versus-host disease clinical onset. Journal of Leukocyte Biology. 2025. doi:10.1093/jleuko/qiae229
BibTeX
@article{Martins2025,
author = {Martins, Filipe and Planet, Evarist and Marino, Denis and Ansari, Marc and Trono, Didier},
title = {Single-cell transcriptome analysis reveals atypical monocytes circulating ahead of acute graft-versus-host disease clinical onset},
journal = {Journal of Leukocyte Biology},
year = {2025},
doi = {10.1093/jleuko/qiae229}
}
EUVIMED